Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial

H. Ludwig, A. Cortelezzi, W. Scheithauer, B. G K van Camp, R. Kuzmits, G. Fillet, M. Peetermans, E. Polli, R. Flener

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences